First Time Loading...

Chemomab Therapeutics Ltd
NASDAQ:CMMB

Watchlist Manager
Chemomab Therapeutics Ltd Logo
Chemomab Therapeutics Ltd
NASDAQ:CMMB
Watchlist
Price: 0.87 USD -0.23% Market Closed
Updated: May 18, 2024

Chemomab Therapeutics Ltd
EPS (Diluted)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Chemomab Therapeutics Ltd
EPS (Diluted) Peer Comparison

Comparables:
CLGN
KMDA
URGN
ENTX
B
BONS

Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
Chemomab Therapeutics Ltd
NASDAQ:CMMB
EPS (Diluted)
-$2
CAGR 3-Years
26%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Collplant Biotechnologies Ltd
NASDAQ:CLGN
EPS (Diluted)
$0
CAGR 3-Years
10%
CAGR 5-Years
15%
CAGR 10-Years
N/A
Kamada Ltd
NASDAQ:KMDA
EPS (Diluted)
$0
CAGR 3-Years
-27%
CAGR 5-Years
-23%
CAGR 10-Years
N/A
Urogen Pharma Ltd
NASDAQ:URGN
EPS (Diluted)
-$3
CAGR 3-Years
16%
CAGR 5-Years
6%
CAGR 10-Years
N/A
Entera Bio Ltd
NASDAQ:ENTX
EPS (Diluted)
$0
CAGR 3-Years
20%
CAGR 5-Years
19%
CAGR 10-Years
N/A
B
Bonus Biogroup Ltd
TASE:BONS
EPS (Diluted)
₪0
CAGR 3-Years
-96%
CAGR 5-Years
-50%
CAGR 10-Years
-10%

See Also

What is Chemomab Therapeutics Ltd's EPS (Diluted)?
EPS (Diluted)
-2.1 USD

Based on the financial report for Dec 31, 2023, Chemomab Therapeutics Ltd's EPS (Diluted) amounts to -2.1 USD.

What is Chemomab Therapeutics Ltd's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 3Y
26%

Over the last year, the EPS (Diluted) growth was -6%. The average annual EPS (Diluted) growth rates for Chemomab Therapeutics Ltd have been 26% over the past three years .